170 related articles for article (PubMed ID: 2349682)
1. Influence of different parameters for the monitoring of cyclosporine.
Humbert H; Vernillet L; Cabiac MD; Barradas J; Billaud E
Transplant Proc; 1990 Jun; 22(3):1210-5. PubMed ID: 2349682
[No Abstract] [Full Text] [Related]
2. Quality assessment of cyclosporine monitoring--Canadian validations.
Wong PY; Mee AV; Glenn J; Keown PA
Transplant Proc; 1990 Jun; 22(3):1216-7. PubMed ID: 2349683
[No Abstract] [Full Text] [Related]
3. An evaluation of cyclosporine monitoring by nonselective fluorescence polarization immunoassay.
Pesce AJ; Schroeder TJ; First MR
Transplant Proc; 1990 Jun; 22(3):1171-4. PubMed ID: 2190376
[No Abstract] [Full Text] [Related]
4. French multicentre study: comparison of two specific and four nonspecific methods for Sandimmune (cyclosporine) blood and plasma (separated at 37 degrees C or at 22 degrees C) monitoring.
Vernillet L; Humbert H; Aupetit B; Berard M; Bertault-Peres P; Billaud E; Bizollon CA; Breteau M; Brisson AM; Codet JP
Transplant Proc; 1990 Jun; 22(3):1218-23. PubMed ID: 2190383
[No Abstract] [Full Text] [Related]
5. A prospective study of cyclosporine monitoring in renal transplantation.
Lindholm A
Transplant Proc; 1990 Jun; 22(3):1260-3. PubMed ID: 2190388
[No Abstract] [Full Text] [Related]
6. Quality assessment of cyclosporine measurements: comparison of current methods.
Holt DW; Marsden JT; Johnston A
Transplant Proc; 1990 Jun; 22(3):1234-9. PubMed ID: 2190385
[No Abstract] [Full Text] [Related]
7. Performance of the Sandoz radioimmunoassays for cyclosporine.
Holt DW; Marsden JT; Fashola TO; Johnston A
Transplant Proc; 1990 Jun; 22(3):1155-9. PubMed ID: 2349678
[No Abstract] [Full Text] [Related]
8. A limited sampling strategy for the measurement of cyclosporine AUC.
Johnston A; Sketris I; Marsden JT; Galustian CG; Fashola T; Taube D; Pepper J; Holt DW
Transplant Proc; 1990 Jun; 22(3):1345-6. PubMed ID: 2349694
[No Abstract] [Full Text] [Related]
9. Liver transplantation in Birmingham--use of cyclosporine--clinical correlations with drug measurements.
Gunson BK; Jones SR; Buckels JA; Jain AB; McMaster P
Transplant Proc; 1990 Jun; 22(3):1312-8. PubMed ID: 2349692
[No Abstract] [Full Text] [Related]
10. Steady-state concentrations of cyclosporine for therapeutic monitoring.
Grevel J; Napoli KL; Kahan BD
Transplant Proc; 1990 Jun; 22(3):1339-42. PubMed ID: 2190397
[No Abstract] [Full Text] [Related]
11. Clinical evaluation and therapeutic range of cyclosporine A as monitored by FPIA in kidney transplantation.
Nattermann U; Steimer W; Gokel JM; Seidel D; Land W
Transplant Proc; 1990 Jun; 22(3):1284-6. PubMed ID: 2190391
[No Abstract] [Full Text] [Related]
12. Cyclophilin binding: a receptor-mediated approach to monitoring cyclosporine immunosuppressive activity following organ transplantation.
Lorber MI; Paul K; Harding MW; Handschumacher RE; Marks WH
Transplant Proc; 1990 Jun; 22(3):1240-4. PubMed ID: 2190386
[No Abstract] [Full Text] [Related]
13. Value of cyclosporine measurements in renal transplant recipients immunosuppressed with triple therapy.
Taube D; Marsden J; Palmer A; Cairns T; Johnston A; Holt DW
Transplant Proc; 1990 Jun; 22(3):1251-2. PubMed ID: 2349686
[No Abstract] [Full Text] [Related]
14. Japanese conference on cyclosporine blood level monitoring.
Takagi H; Uchida K
Transplant Proc; 1990 Jun; 22(3):1224-5. PubMed ID: 2190384
[No Abstract] [Full Text] [Related]
15. Biologic activity of cyclosporine metabolites.
Sewing KF; Christians U; Kohlhaw K; Radeke H; Strohmeyer S; Kownatzki R; Budniak J; Schottmann R; Bleck JS; Almeida VM
Transplant Proc; 1990 Jun; 22(3):1129-34. PubMed ID: 2349673
[No Abstract] [Full Text] [Related]
16. Summary on therapeutic drug monitoring for renal transplantation.
Kahan BD
Transplant Proc; 1990 Jun; 22(3):1348-51. PubMed ID: 2190398
[No Abstract] [Full Text] [Related]
17. Nonselective measurement of cyclosporine for therapeutic drug monitoring by fluorescence polarization immunoassay with a sheep polyclonal antibody: II. Evaluation of the whole blood methodology and comparison with an 3H tracer-mediated radioimmunoassay with a sheep polyclonal antibody.
Napoli KL; Kahan BD
Transplant Proc; 1990 Jun; 22(3):1181-5. PubMed ID: 2190378
[No Abstract] [Full Text] [Related]
18. Impact of lipoproteins on cyclosporine pharmacokinetics and biological activity in transplant patients.
Awni WM; Heim-Duthoy K; Kasiske BL
Transplant Proc; 1990 Jun; 22(3):1193-6. PubMed ID: 2349681
[No Abstract] [Full Text] [Related]
19. Late cyclosporine conversion carries risk of irreversible rejection.
Sagalowsky AI; Reisman ME; Dawidson I; Toto R; Peters PC; Helderman JH
Transplant Proc; 1988 Jun; 20(3 Suppl 3):157-60. PubMed ID: 3291233
[No Abstract] [Full Text] [Related]
20. Adjustment of cyclosporine dosage in renal transplant patients based on concentration measured specifically in whole blood: clinical outcome results and diagnostic utility.
Shaw LM; Audet PR; Grossman RA; Fields L; Lensmeyer GL; Dafoe DC
Transplant Proc; 1990 Jun; 22(3):1267-73. PubMed ID: 2349688
[No Abstract] [Full Text] [Related]
[Next] [New Search]
